AUTHOREA
Log in Sign Up Browse Preprints

loading page

A Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor Successfully Treated with Combination Ipilimumab-Nivolumab
  • +3
  • Yoshio NAKANO,
  • Daisuke Sekinada,
  • Yusuke Kuze,
  • Norio Okamoto,
  • Iwao GOHMA,
  • Yumiko Yasuhara
Yoshio NAKANO
Sakai City Medical Center

Corresponding Author:[email protected]

Author Profile
Daisuke Sekinada
Sakai City Medical Center
Author Profile
Yusuke Kuze
Sakai City Medical Center
Author Profile
Norio Okamoto
Sakai City Medical Center
Author Profile
Iwao GOHMA
Sakai City Medical Center
Author Profile
Yumiko Yasuhara
Sakai City Medical Center
Author Profile

Abstract

Thoracic SMARCA4-deficient undifferentiated tumors are rare, with poor prognosis. A 73-year-old man presented to our hospital with dyspnea. Computed tomography-guided biopsy revealed a SMARCA4-deficient undifferentiated tumor. The patient was treated with combination ipilimumab-nivolumab. The tumor reduced in size after two courses.

Peer review status:Published

03 Oct 2022Submitted to Clinical Case Reports
Show details
Hide details
05 Oct 2022Submission Checks Completed
05 Oct 2022Assigned to Editor
11 Oct 2022Reviewer(s) Assigned
09 Nov 2022Review(s) Completed, Editorial Evaluation Pending
09 Nov 2022Editorial Decision: Revise Minor
21 Nov 20221st Revision Received
23 Nov 2022Submission Checks Completed
23 Nov 2022Assigned to Editor
23 Nov 2022Review(s) Completed, Editorial Evaluation Pending
01 Dec 2022Editorial Decision: Accept
Dec 2022Published in Clinical Case Reports volume 10 issue 12. 10.1002/ccr3.6745